Kassira Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.94M Sell
7,702
-44
-0.6% -$9.47K 1.55% 20
2026
Q1
$1.68M Buy
7,746
+353
+5% +$78.3K 1.55% 20
2025
Q4
$1.69M Sell
7,393
-105
-1% -$23.9K 1.6% 21
2025
Q3
$1.74M Buy
+7,498
New +$1.53M 1.67% 22

Other funds holding ABBV

Kassira Wealth Management's ABBV Position: Q2 2026 in Review

Kassira Wealth Management reduced its AbbVie (ABBV) stake by 0.57% in Q2 2026, selling an estimated $9.47K and leaving 7,702 shares worth $1.94M. The position accounts for 1.55% of the portfolio, ranked #20.

Kassira Wealth Management first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kassira Wealth Management held 7,702 shares of AbbVie worth $1.94M as of Q2 2026.
  • Kassira Wealth Management sold 44 AbbVie shares in Q2 2026, an estimated $9.47K.
  • AbbVie made up 1.55% of Kassira Wealth Management's portfolio in Q2 2026, its #20 holding.
  • Kassira Wealth Management first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kassira Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.